Amid the tragedy of the pandemic, one marvel is hiding in plain sight. The development of a working vaccine against SARS-CoV-2 is happening at breakneck speed, a triumph of ingenuity and efficiency that has few precedents.
However, even if researchers and pharmaceutical companies succeed on the scientific front, policy makers will then have to pick up the baton. Unfortunately, if the poor management of the pandemic in Europe and the United States is any guidance, the potential for policy failure is enormous.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
PHOTO GALLERY (CLICK TO ENLARGE)
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.